These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 9840093
21. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis. Weinberg WC, Montano NE, Deng C. Oncogene; 1997 Aug 07; 15(6):685-90. PubMed ID: 9264409 [Abstract] [Full Text] [Related]
22. Comparative evaluation of the expression of cell cycle regulating proteins: cyclin D1, P53 and P21 (WAF1) in colorectal cancer. Pasz-Walczak G, Kordek R. Pol J Pathol; 2000 Aug 07; 51(2):63-9. PubMed ID: 10974928 [Abstract] [Full Text] [Related]
23. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. Chao CH, Chen CM, Cheng PL, Shih JW, Tsou AP, Lee YH. Cancer Res; 2006 Jul 01; 66(13):6579-88. PubMed ID: 16818630 [Abstract] [Full Text] [Related]
24. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation. Le NT, Richardson DR. Carcinogenesis; 2003 Jun 01; 24(6):1045-58. PubMed ID: 12807743 [Abstract] [Full Text] [Related]
25. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin. Huang S, Liu LN, Hosoi H, Dilling MB, Shikata T, Houghton PJ. Cancer Res; 2001 Apr 15; 61(8):3373-81. PubMed ID: 11309295 [Abstract] [Full Text] [Related]
26. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer]. Yan XJ, Liang LZ, Li DC, Li JL, Zhang CQ, Yuan SH. Ai Zheng; 2004 Jan 15; 23(1):74-80. PubMed ID: 14720380 [Abstract] [Full Text] [Related]
27. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma. Mitani Y, Oue N, Hamai Y, Aung PP, Matsumura S, Nakayama H, Kamata N, Yasui W. J Pathol; 2005 Jan 15; 205(1):65-73. PubMed ID: 15586362 [Abstract] [Full Text] [Related]
28. p21(WAF1) expression and endocrine response in breast cancer. McClelland RA, Gee JM, O'Sullivan L, Barnes DM, Robertson JF, Ellis IO, Nicholson RI. J Pathol; 1999 Jun 15; 188(2):126-32. PubMed ID: 10398154 [Abstract] [Full Text] [Related]
29. Clinical significance of p21(WAF1/CIP1) and p53 expression in serous cystadenocarcinoma of the ovary. Terauchi F, Okamoto A, Nagashima T, Kobayashi Y, Moritake T, Yamamoto Y, Takakura S, Iwaki S, Ogura H. Oncol Rep; 2005 Aug 15; 14(2):363-8. PubMed ID: 16012716 [Abstract] [Full Text] [Related]
30. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis. Suzuki Y, Nakano T, Kato S, Ohno T, Tsujii H, Oka K. Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):231-6. PubMed ID: 15337561 [Abstract] [Full Text] [Related]
31. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, El-Naggar AK. Int J Oncol; 2003 Feb 01; 22(2):409-14. PubMed ID: 12527941 [Abstract] [Full Text] [Related]
32. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest. Patel V, Lahusen T, Sy T, Sausville EA, Gutkind JS, Senderowicz AM. Cancer Res; 2002 Mar 01; 62(5):1401-9. PubMed ID: 11888912 [Abstract] [Full Text] [Related]
33. p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression. Choi BH, Kim CG, Bae YS, Lim Y, Lee YH, Shin SY. Cancer Res; 2008 Mar 01; 68(5):1369-77. PubMed ID: 18316600 [Abstract] [Full Text] [Related]
34. Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas. Hui AM, Kanai Y, Sakamoto M, Tsuda H, Hirohashi S. Hepatology; 1997 Mar 01; 25(3):575-9. PubMed ID: 9049201 [Abstract] [Full Text] [Related]
35. p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma. Schmider A, Gee C, Friedmann W, Lukas JJ, Press MF, Lichtenegger W, Reles A. Gynecol Oncol; 2000 May 01; 77(2):237-42. PubMed ID: 10785471 [Abstract] [Full Text] [Related]
36. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Biankin AV, Kench JG, Morey AL, Lee CS, Biankin SA, Head DR, Hugh TB, Henshall SM, Sutherland RL. Cancer Res; 2001 Dec 15; 61(24):8830-7. PubMed ID: 11751405 [Abstract] [Full Text] [Related]
37. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells. Liu J, Estes ML, Drazba JA, Liu H, Prayson R, Kondo S, Jacobs BS, Barnett GH, Barna BP. Oncogene; 2000 Feb 03; 19(5):661-9. PubMed ID: 10698511 [Abstract] [Full Text] [Related]
38. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy. Levesque MA, Katsaros D, Massobrio M, Genta F, Yu H, Richiardi G, Fracchioli S, Durando A, Arisio R, Diamandis EP. Clin Cancer Res; 2000 Aug 03; 6(8):3260-70. PubMed ID: 10955812 [Abstract] [Full Text] [Related]